Alzheimer’s Research & Therapy (May 2020)

Is it time to use real-world data from primary care in Alzheimer’s disease?

  • Anna Ponjoan,
  • Josep Garre-Olmo,
  • Jordi Blanch,
  • Ester Fages,
  • Lia Alves-Cabratosa,
  • Ruth Martí-Lluch,
  • Marc Comas-Cufí,
  • Dídac Parramon,
  • María Garcia-Gil,
  • Rafel Ramos

DOI
https://doi.org/10.1186/s13195-020-00625-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background The analysis of real-world data in clinical research is rising, but its use to study dementia subtypes has been hardly addressed. We hypothesized that real-world data might be a powerful tool to update AD epidemiology at a lower cost than face-to-face studies, to estimate the prevalence and incidence rates of AD in Catalonia (Southern Europe), and to assess the adequacy of real-world data routinely collected in primary care settings for epidemiological research on AD. Methods We obtained data from the System for the Development of Research in Primary Care (SIDIAP) database, which contains anonymized information of > 80% of the Catalan population. We estimated crude and standardized incidence rates and prevalences (95% confidence intervals (CI)) of AD in people aged at least 65 years living in Catalonia in 2016. Results Age- and sex-standardized prevalence and incidence rate of AD were 3.1% (95%CI 2.7–3.6) and 4.2 per 1000 person-years (95%CI 3.8–4.6), respectively. Prevalence and incidence were higher in women and in the oldest people. Conclusions Our incidence and prevalence estimations were slightly lower than the recent face-to-face studies conducted in Spain and higher than other analyses of electronic health data from other European populations. Real-world data routinely collected in primary care settings could be a powerful tool to study the epidemiology of AD.

Keywords